MALAT1 and neoplasm: When MALAT1 was knocked down with ASO-MALAT1 in xenograft tumors derived from HBx-expressing HepG2 cells, significantly smaller tumor sizes, weights, and volumes were detected than in the HBx+ASO-NC group (Fig. 6B-D).